An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox

Authors: Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Haruka Iwasaki, Rina Yano, Tetsuya Suzuki, Sho Saito, Nobumasa Okumura, Wataru Sugiura, Norio Ohmagari, Mugen Ujiie

Source: Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)

Subject Terms: mpox, smallpox vaccine, mpox vaccine, open-label, non-randomized study, post-exposure prophylaxis, lc16, adverse events, vaccine safety, vaccine efficacy, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/e3e544fff4fa4f90941f5e86a84fb157